Akebia Therapeutics (NQ: AKBA )
1.530
+0.060
(+4.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Akebia Therapeutics
![](https://cdn.benzinga.com/files/images/story/2022/12/07/screenshot_2022-12-07_at_5.53.32_pm.png?width=1200&height=800&fit=crop)
Looking Into Akebia Therapeutics's Return On Capital Employed
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5762.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19588.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/11/shutterstock_1568130019.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2561.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/05/aapharma_10.png?width=1200&height=800&fit=crop)
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
August 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_281.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/10/image21.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/27/image_3.jpg?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/907211960/HrjBQ9z3.png)
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 23, 2022
Via TheNewswire.com
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2022/09/22/screenshot_2022-09-22_at_6.35.33_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/05/brain-g5e2c29340_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/29/image-amazon2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/05/image_3.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/rev_revlon1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image_6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image39.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image36.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/face-mask-gcd59977aa_1280.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11622.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image10.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11605.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/30/stock-market-2616931_1280_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/30/image31.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.